Back

May we overcome the current serious limitations for distributing reconstituted mRNA vaccines?

Grau, S.; Ferrandez, O.; Martin-Garcia, E.; Maldonado, R.

2021-03-12 pharmacology and therapeutics
10.1101/2021.03.09.21253129 medRxiv
Show abstract

There is an urgent need to ameliorate the transport of the reconstituted vaccines to the vaccination sites to improve the COVID-19 vaccination campaigns. The maintenance of the integrity of the mRNA of the different COVID-19 reconstituted vaccines after continuous movement at room temperature during at least three hours ensures the safety of a ground transportation.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.